Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 726K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Masuyama, J.-i. Articles by Minota, S. Search for Related Content PubMed PubMed Citation Articles by Masuyama, J.-i. Articles by Minota, S. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                            What's this?

Articles

Jun-ichi Masuyama^*, Taku Yoshio^*, Kenichi Suzuki, Seiichi Kitagawa, Masahiro Iwamoto^*, Takeshi Kamimura^*, Daisuke Hirata^*, Akira Takeda^*, Shogo Kano^*, and Seiji Minota^*

From the ^* Division of Rheumatology and Clinical Immunology, Jichi Medical School, Tochigi 329-04, Japan; and the Second Department of Physiology, Osaka City University Medical School, Osaka 545, Japan

In extravasation of T cells, little is known about the mechanisms of transendothelial migration subsequent to the T cells' tight adhesion to endothelium. To investigate these mechanisms, we developed a monoclonal antibody (mAb), termed anti-4C8, that blocks transmigration but not adhesion in a culture system in which high CD26–expressing (CD26^hi) T cells preferentially migrate through human umbilical vein endothelial cell (HUVEC) monolayers cultured on collagen gels. Anti-4C8 reacted with all CD3⁺ T cells and monocytes but not neutrophils or HUVECs. The structure defined by this antibody was an 80-kD molecule. The mAb at 1 µg/ml inhibited 80–90% of migration of CD3⁺ T cells through unstimulated and interferon –stimulated HUVEC monolayers without interfering with adhesion and cell motility. When added to the cultures after the adhesion, anti-4C8 completely blocked subsequent transmigration of adherent T cells. Phase–contrast and electron microscopy revealed that T cells are arrested at the intercellular junctions of HUVECs in the presence of anti-4C8. Anti-4C8 exhibited agonistic effects on resting T cells without other stimuli under culture conditions in which anti-4C8 can stimulate T cells. First, in the checkerboard assay using collagen gels, the antibody promoted chemokinetic migration of the cells in a dose-dependent manner from 0.1 to 10 µg/ml. The predominant population of T cells that migrated into collagen gels with impregnated anti-4C8 were CD26^hi. Second, solid-phase–immobilized anti-4C8 induced adhesion of T cells to the substrate, often with polarizations in cell shape and large pseudopods rich in filamentous (F-) actin. Third, soluble anti-4C8 augmented F-actin content preferentially in CD26^hi T cells when added to T cells at a high dose of 10 µg/ml. Finally, both anti-4C8–induced chemokinetic migration and transendothelial migration were inhibited by pretreatment of T cells with pertussis toxin. These findings suggest that stimulation via the 4C8 antigen increases cell motility of CD26^hi cells with profound cytoskeletal changes through signaling pathways including G proteins. The 4C8 antigen may be involved in preferential transmigration of CD26^hi cells adherent to HUVECs.

Key Words: lymphocyte • transmigration • mechanism • cell motility • actin polymerization

Abbreviations used: DFP, diisopropyl fluorophosphate; EC, endothelial cell; ECGS, EC growth supplement; F-actin, filamentous actin; HUVEC, human umbilical vein EC; ICAM-1, intercellular adhesion molecule-1; MCP-1, monocyte chemoattractant protein-1; PECAM-1, platelet–endothelial cell adhesion molecule-1; PT, pertussis toxin.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS